Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

7.38
Delayed Data
As of Aug 04
 -0.15 / -1.99%
Today’s Change
3.44
Today|||52-Week Range
8.83
+65.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues3.8M4.2M4.3M4.5M
 
 
 
 
 
Cost of Goods Sold893.0K1.1M879.5K1.0M
 
 
 
 
 
Depreciation And Amortization14.1K12.7K12.6K13.6K
 
 
 
 
 
 
Operating ExpensesGross Income2.8M3.1M3.4M3.4M
 
 
 
 
 
General Expenses13.8M21.0M19.7M24.3M
 
 
 
 
 
Research And Development8.2M14.9M14.2M18.2M
 
 
 
 
 
Total Operating Expenses14.7M22.0M20.6M25.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.9M-17.8M-16.3M-20.9M
 
 
 
 
 
Other Expenses18.6K6.3K3.2K18.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.9M-17.8M-16.3M-20.9M
 
 
 
 
 
Net Income-10.9M-17.8M-16.3M-20.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS145.5M152.2M156.1M163.4M
 
 
 
 
 
Shares To Calculate EPS Diluted145.5M152.2M156.1M163.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.12-$0.10-$0.13
 
 
 
 
 
EPS Diluted-$0.07-$0.12-$0.10-$0.13